Market Overview:
The global intragastric balloons market size reached US$ 63.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 157.8 Million by 2032, exhibiting a growth rate (CAGR) of 10.3% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 63.6 Million |
Market Forecast in 2032
|
US$ 157.8 Million |
Market Growth Rate 2024-2032 |
10.3% |
An intragastric balloon is a saline- or gas-filled inflatable silicone balloon that is temporarily placed inside the stomach for losing weight. It is inserted through a non-surgical endoscopic procedure to confine the amount of food stored by the stomach, thereby providing an early feeling of satiety. It also aids in preserving the anatomy of the stomach and is bio-compatible while having negligible or no side-effects. As a result, the device is commonly used by individuals suffering from obesity and having a body mass index (BMI) ranging from 30 to 70.
The increasing prevalence of obesity is one of the key factors driving the growth of the market. Owing to sedentary lifestyles and unhealthy eating habits, a significant portion of the world's population is suffering from weight-related health concerns. This has consequently augmented the demand for various medically certified weight-loss procedures, including intragastric balloons. Furthermore, growing consumer preference for minimally invasive (MI) surgeries is also providing a boost to the market growth. Intragastric balloons serve as an effective non-surgical alternative for weight-loss as they are inserted orally and do not require any incisions on the body. Additionally, various technological advancements and product innovations are also creating a positive outlook for the market growth. Manufacturers are focusing on creating product variants with minimal side-effects, such as ulceration, gastric erosion and nausea, and are also designing balloons with adjustable gas/saline volumes. Other factors, including increasing health consciousness among consumers, and extensive research and development (R&D) activities, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global intragastric balloons market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, filling material, implanting procedure, application and end-user.
Breakup by Product:
- Single Intragastric Balloon
- Double Intragastric Balloon
- Triple Intragastric Balloon
Breakup by Filling Material:
- Saline Filling
- Gas Filling
Breakup by Implanting Procedure:
Breakup by Application:
- Obesity
- Diabetes
- Diet Control
- Weight-Loss
- Pre-Operative Weight Reduction
- Others
Breakup by End-User:
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Apollo Endosurgery, Obalon Therapeutics Inc., ReShape Medical Inc., Medicone, Medsil, Allurion Technologies Inc., Helioscopie, Spatz Fgia Inc., PlenSat, Districlass Medical SA, Endalis, Lexel SRL, Silimed Inc., Shandong Institute of Medical Instruments, etc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Million |
Segment Coverage |
Product, Filling Material, Implanting Procedure, Application, End-User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Apollo Endosurgery, Obalon Therapeutics Inc., ReShape Medical Inc., Medicone, Medsil, Allurion Technologies Inc., Helioscopie, Spatz Fgia Inc., PlenSat, Districlass Medical SA, Endalis, Lexel SRL, Silimed Inc. and Shandong Institute of Medical Instruments |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global intragastric balloons market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global intragastric balloons market?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the filling material?
- What is the breakup of the market based on the implanting procedure?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global intragastric balloons market and who are the key players?
- What is the degree of competition in the industry?